Eli Lilly to Acquire Houston Biotech Startup CrossBridge Bio
Eli Lilly is doubling down on the region with the acquisition of local biotech startup CrossBridge Bio.
Houston: A Global Hub for Life Sciences and Biotechnology
Houston: A Global Hub for Life Sciences and Biotechnology
As one of the fastest growing life sciences ecosystems, Houston’s world-class medical centers, research institutions and private companies are positioned to take on the greatest medical challenges of our generation.
Join Us!
ATTENDING BIO INTERNATIONAL 2026?
Join us at Booth #4700 from June 22-25, 2026 to learn more about Houston's growing life science ecosystem!
Learn More
Houston's Life Sciences Ecosystem
With $1 billion in annual research investment, Houston offers leading companies access to the youngest, fastest growing and most diverse workforces in the country, powered by strategic upskilling and academic collaborations.
0.0k+
Life Sciences and Biotechnology Companies
$0.00B
NIH Research Funding
(2020 - 2025)
0M sq ft
Life Sciences Space
#0
Largest Medical Center in the World
0.0k+
Clinical trials with active site in Houston
National Security Commission on Emerging Biotechnology Explores Houston
Houston’s biotech industry continues to drive interest and investment.
Built Here, Growing Here
Houston’s MedTech momentum is not new, it is the natural evolution of a legacy that continues to scale, attract investment and shape the future of health.
News | September 23, 2025
Houston Wins Texas' First Major Pharma Plant With $6.5B Investment
Eli Lilly and Company is investing $6.5 billion into Houston's Generation Park to build a 236-acre manufacturing facility, creating more than 615 jobs.
Get in touch with our team to assist with additional questions about Houston, such as:
- Assist in site selection analysis
- Assist in evaluating and applying for incentives
- Provide data on key business facilities
- Facilitate and foster key introductions
